Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?

American Journal of Clinical Pathology

Volumn 118, Issue 3, 2002, Pages 425-434

  Goldstein, Neal S ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast; Carcinoma; Ductal; E cadherin; Immunohistochemistry; Lobular; Metastases

Indexed keywords

UVOMORULIN; CADHERIN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; BREAST LOBULAR CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CARCINOMA CELL; CELL ADHESION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; METASTASIS; MIXED TUMOR; PERMEABILITY; PRIORITY JOURNAL; STAINING; BREAST TUMOR; CELL NUCLEUS; CLASSIFICATION; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS;

EID: 0036718149     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/JMRD-W08Y-6K8M-7AD8     Document Type: Article

References (59)

1. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-120.
2. Lamovec J, Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol. 1991;48:28-33.
3. Dixon AR, Ellis IO, Elston CW, et al. A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. Br J Cancer. 1991;63:634-635.
4. Wilkinson MJ, Howell A, Harris M, et al. Retroperitoneal tumour infiltration detected by bone scanning in patients with infiltrating lobular carcinoma of the breast. Br J Surg. 1985;72:626-628.
5. Smith DB, Howell A, Harris M, et al. Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast. Eur J Surg Oncol. 1985;11:33-36.
6. Harris M, Howell A, Chrissohou M, et al. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer. 1984;50:23-30.
7. Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery. 1993;114:637-642.
8. Lamovec J, Zidar A. Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. Arch Pathol Lab Med. 1991;115:507-510.
9. Voravud N, el Naggar AK, Balch CM, et al. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992;15:365-369.
10. Jayson GC, Howell A, Harris M, et al. Carcinomatous meningitis in patients with breast cancer. Cancer. 1994;74:3135-3141.
11. Cormier WJ, Gaffey TA, Welch JM, et al. Linitis plastica caused by metastatic lobular carcinoma of the breast. Mayo Clin Proc. 1980;55:747-753.
12. Kumar ND, Hart WR. Metastases to the uterine corpus from extragenital cancers. Cancer. 1982;50:2163-2169.
13. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 1993;9:317-321.
14. Steinberg MS, McNutt PM. Cadherins and their connections: adhesion junctions have broader functions. Curr Opin Cell Biol. 1999;11:554-560.
15. Heimann R, Lan F, McBride R, et al. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res. 2000;60:298-304.
16. Huiping C, Sigurgeirsdottir JR, Jonasson JG, et al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer. 1999;81:1103-1110.
17. 1-integrins in invasive breast cancer. J Pathol. 1999;187:523-529.
18. Bankfalvi A, Terpe HJ, Breukelmann D, et al. Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology. 1999;34:25-34.
19. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997;183:404-411.
20. Vos CB, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997;76:1131-1133.
21. Nishizaki T, Chew K, Chu L, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer. 1997;74:513-517.
22. Charpin C, Garcia S, Bouvier C, et al. E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol. 1997;181:294-300.
23. Zschiesche W, Schonborn I, Behrens J, et al. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res. 1997;17:561-567.
24. Berx G, Cleton-Jansen AM, Strumane K, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996;13:1919-1925.
25. Jones JL, Royall JE, Walker RA. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer. 1996;74:1237-1241.
26. Hashizume R, Koizumi H, Ihara A, et al. Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology. 1996;29:139-146.
27. Siitonen SM, Kononen JT, Helin HJ, et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol. 1996;105:394-402.
28. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107-6115.
29. Palacios J, Benito N, Pizarro A, et al. Relationship between ERBB2 and E-cadherin expression in human breast cancer. Virchows Arch. 1995;427:259-263.
30. Ochiai A, Akimoto S, Shimoyama Y, et al. Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth. Jpn J Cancer Res. 1994;85:266-273.
31. Moll R, Mitze M, Frixen UH, et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol. 1993;143:1731-1742.
32. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol. 1993;142:987-993.
33. Rasbridge SA, Gillett CE, Sampson SA, et al. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol. 1993;169:245-250.
34. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993;53:1696-1701.
35. Charpin C, Garcia S, Bonnier P, et al. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am J Clin Pathol. 1998;109:431-438.
36. Lipponen PK, Saarelainen E, Ji H, et al. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol. 1994;174:101-109.
37. Asgeirsson KS, Jonasson JG, Tryggvadottir L, et al. Altered expression of E-cadherin in breast cancer: patterns, mechanisms, and clinical significance. Eur J Cancer. 2000;36:1098-1106.
38. Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol. 2001;115:85-98.
39. Cheng CW, Wu PE, Yu JC, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene. 2001;20:3814-3823.
40. Droufakou S, Deshmane V, Roylance R, et al. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Inc J Cancer. 2001;92:404-408.
41. Waldman FM, Hwang ES, Etzell J, et al. Genomic alterations in tubular breast carcinomas. Hum Pathol. 2001;32:222-226.
42. Foote FW Jr, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17:491-495.
43. Fechner RE. Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol. 1975;6:373-378.
44. Elston CW, Ellis IO. Pathologic prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology. 1991;19:403-410.
45. Buerger H, Otterbach F, Simon R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol. 1999;189:521-526.
46. Flagiello D, Gerbault-Seureau M, Sastre-Garau X, et al. Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer. 1998;23:300-306.
47. Kouvaraki M, Gorgoulis VG, Rassidakis GZ, et al. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors. Anticancer Res. 2001;21:991-999.
48. Chalmers IJ, Aubele M, Hartmann E, et al. Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer. Cancer Genet Cycogenet. 2001;126:39-44.
49. Kanai Y, Oda T, Tsuda H, et al. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res. 1994;85:1035-1039.
50. Kashiwaba M, Tamura G, Suzuki Y, et al. Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res. 1995;86:1054-1059.
51. Becker KF, Reich U, Schott C, et al. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215 [serial online]. Hum Mutat. 1999;13:171. Available at: http://journals.wiley.com/1059-7794/pdf/mutation/215.pdf. Accessed July 2, 2002.
52. van de WM, Barker N, Harkes IC, et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res. 2001;61:278-284.
53. Dorion-Bonnet F, Mautalen S, Hostein I, et al. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer. 1995;14:171-181.
54. Iida A, Isobe R, Yoshimoto M, et al. Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br J Cancer. 1997;75:264-267.
55. Graff JR, Herman JG, Lapidus RG, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995;55:5195-5199.
56. Berx G, Staes K, van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDHI). Genomics. 1995;26:281-289.
57. Toyooka KO, Toyooka S, Virmani AK, et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 2001;61:4556-4560.
58. Bukholm IK, Nesland JM, Karesen R, et al. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol. 1998;185:262-266.
59. Korman NJ, Erye RW, Klaus-Kovtun V, et al. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med. 1989;321:631-635.